Author
Listed:
- Olivier Guillin
(Unité de Neurobiologie et Pharmacologie Moléculaire, INSERM U 109, Centre Paul Broca)
- Jorge Diaz
(Laboratoire de Physiologie, Université René Descartes)
- Patrick Carroll
(Unité de Développement et Pathologie du Motoneurone Spinal, INSERM U 382, IBDM, Campus de Luminy)
- Nathalie Griffon
(Unité de Neurobiologie et Pharmacologie Moléculaire, INSERM U 109, Centre Paul Broca)
- Jean-Charles Schwartz
(Unité de Neurobiologie et Pharmacologie Moléculaire, INSERM U 109, Centre Paul Broca
Laboratoire de Physiologie, Université René Descartes)
- Pierre Sokoloff
(Unité de Neurobiologie et Pharmacologie Moléculaire, INSERM U 109, Centre Paul Broca)
Abstract
Brain-derived neurotrophic factor (BDNF), like other neurotrophins, is a polypeptidic factor initially regarded to be responsible for neuron proliferation, differentiation and survival, through its uptake at nerve terminals and retrograde transport to the cell body1. A more diverse role for BDNF has emerged progressively from observations showing that it is also transported anterogradely2,3, is released on neuron depolarization1, and triggers rapid intracellular signals4 and action potentials in central neurons5. Here we report that BDNF elicits long-term neuronal adaptations by controlling the responsiveness of its target neurons to the important neurotransmitter, dopamine. Using lesions and gene-targeted mice lacking BDNF, we show that BDNF from dopamine neurons is responsible for inducing normal expression of the dopamine D3 receptor in nucleus accumbens6,7,8 both during development and in adulthood. BDNF from corticostriatal neurons3 also induces behavioural sensitization, by triggering overexpression of the D3 receptor in striatum of hemiparkinsonian rats9. Our results suggest that BDNF may be an important determinant of pathophysiological conditions such as drug addiction10, schizophrenia11 or Parkinson's disease12, in which D3 receptor expression is abnormal.
Suggested Citation
Olivier Guillin & Jorge Diaz & Patrick Carroll & Nathalie Griffon & Jean-Charles Schwartz & Pierre Sokoloff, 2001.
"BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization,"
Nature, Nature, vol. 411(6833), pages 86-89, May.
Handle:
RePEc:nat:nature:v:411:y:2001:i:6833:d:10.1038_35075076
DOI: 10.1038/35075076
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:411:y:2001:i:6833:d:10.1038_35075076. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.